Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Falun – page 3

57 clinical trials in Falun, Sweden across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Falun at a glance
57
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

57 trials in Falun

Open in trial search

Pre-eclampsia

Recruiting

Study on Metformin for Prolonging Pregnancy in Women with Preterm Preeclampsia

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Metformin Hydrochloride
  • Sponsor:University Of Gothenburg

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Pulmonary embolism

Not yet recruiting

Reduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:University Of Gothenburg

Abortion induced

Not yet recruiting

Ropivacaine hydrochloride versus electrolytes for pain relief in women undergoing second‑trimester medical abortion after 13 weeks

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Mannitol
  • Sponsor:Karolinska Institutet

Dermatitis atopic

Not yet recruiting

A Study of Lebrikizumab for Adults and Adolescents with Moderate to Severe Atopic Dermatitis to Evaluate Effects on Eczema and Skin Barrier Function

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Lebrikizumab
  • Sponsor:Region Oestergoetland

Colorectal cancer

Not yet recruiting

Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Karolinska Institutet

Abortion induced

Not yet recruiting

Study on Immediate vs. Delayed Insertion of Levonorgestrel IUD for Women After Medical Abortion

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Levonorgestrel
  • Sponsor:Karolinska Institutet

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Obesity

Not recruiting

Study on Maintaining Weight Loss in Teens with Obesity Using Semaglutide

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Falun

What the registry says about research in the country

01 Oncology Research

Innovative trials exploring treatments for multiple myeloma, breast cancer, and lung cancer. Studies include evaluating novel drug combinations and targeted therapies for better patient outcomes.

  • EGFR-mutated lung cancer treatment optimization
  • Advanced breast cancer endocrine therapy
  • Multiple myeloma treatment combinations

Research focuses on personalized treatment approaches and improved survival rates.

02 Cardiovascular Studies

Clinical trials investigating treatments for atrial fibrillation and cardiovascular disease. Research includes stroke prevention and innovative therapies for vascular conditions.

  • Stroke prevention in atrial fibrillation
  • Abdominal aortic aneurysm management
  • Left ventricular thrombosis treatment

Emphasis on comparing novel anticoagulants with standard treatments.

03 Chronic Disease Management

Studies addressing rheumatoid arthritis, COPD, and other chronic conditions. Research evaluates treatment effectiveness and patient outcomes.

  • Early rheumatoid arthritis therapy optimization
  • COPD treatment strategies
  • Diabetic foot ulcer healing

Focus on improving quality of life and disease management approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.